Clinical Trial Update: Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection [EARLY_Phase 1]

View source ↗

Summary

The EARLY Phase 1 trial examining fetal middle cerebral artery Doppler in preterm births receiving magnesium sulfate for neuroprotection has been completed. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Cairo University | Conditions: Preterm Birth | EARLY_Phase 1 | Status: COMPLETED